MarketPeel
Insider Trading Intelligence
Pricing
…
GK

Gilla Kaplan

AVTX
DIRECTOR · AVALO THERAPEUTICS, INC. · CIK 0001247024
FILING MIX · LIFETIME59%/41%
BUYS
19
SELLS
13
TOTAL VALUE
$3.35M
COMPANIES
2
ACTIVE SINCE
Sep 2021
HOLDINGS NOW
20,100
AVG SELL PX
$18.04
TRADE KIND
SHOWING 32 / 32
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Gilla Kaplan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+50.00%-2.89%+0.17%-3.06%-2.41%—
14d6+50.00%-2.61%+2.83%-5.44%-4.10%—
30d6+16.67%+5.96%+5.06%+0.90%+1.61%—
60d6+33.33%+3.09%+7.02%-1.01%-1.77%—
90d6+16.67%+15.15%+10.38%+4.78%+10.10%—
180d6(1 pending)+0.00%+122.55%+13.86%+108.70%+108.31%—
1y6(1 pending)+0.00%+170.80%+24.26%+146.54%+138.84%—
2y6(6 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AVTX · 20,100 shares · as of Jun 2, 2026
011,02922,05833,08644,11520222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 13 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,100——20,100Jun 2, 2026Jun 4, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
3,166——3,167Mar 28, 2026Mar 31, 2026 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
3,166——6,333Mar 28, 2026Mar 31, 2026 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
53,172$37.75$2.01M28,231Mar 26, 2026Mar 27, 2026 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
53,172$2.25$119.6K81,403Mar 26, 2026Mar 27, 2026 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
53,172——0Mar 26, 2026Mar 27, 2026 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
PURCHASE
14,295$2.25$32.2K42,526Mar 25, 2026Mar 27, 2026 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
14,295——53,172Mar 25, 2026Mar 27, 2026 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
14,295$36.97$528.5K28,231Mar 25, 2026Mar 27, 2026 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
9,568$9.78$93.6K28,231Jun 18, 2025Jun 20, 2025 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
10$10.35$10437,799Jun 17, 2025Jun 20, 2025 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,100——20,100Jun 17, 2025Jun 18, 2025 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
6,814$10.38$70.7K37,809Jun 16, 2025Jun 16, 2025 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
15,000$10.31$154.6K44,623Jun 13, 2025Jun 16, 2025 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
30,000$10.31$309.3K59,623Jun 12, 2025Jun 16, 2025 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
22,200——22,200May 29, 2025Jun 2, 2025 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
3,167——3,167Mar 28, 2025Apr 1, 2025 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
3,167——6,333Mar 28, 2025Apr 1, 2025 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,500——9,500Aug 13, 2024Aug 14, 2024 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,600——24,600Aug 13, 2024Aug 14, 2024 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
SALE
61,392——0Jun 13, 2024Jun 13, 2024 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
PURCHASE
61,392$0.61$37.4K89,623Jun 13, 2024Jun 13, 2024 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
18,600——18,600May 29, 2024May 31, 2024 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,334——3,334Dec 20, 2023Dec 21, 2023 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
14,500——14,500May 31, 2023Jun 2, 2023 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,080——3,080Sep 30, 2022Oct 3, 2022 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
44,115——44,115Jun 30, 2022Jul 1, 2022 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 14, 2022Jun 15, 2022 ↗View →
TYRA
TYRA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
14,500——14,500Jun 13, 2022Jun 15, 2022 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,359——30,359Mar 31, 2022Apr 4, 2022 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,767——12,767Dec 31, 2021Jan 4, 2022 ↗View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,541——9,541Sep 30, 2021Oct 4, 2021 ↗View →
Other insiders · AVTX
Loading peer insiders…
About this filer
CIK 0001247024
ROLE
Director
PRIMARY
AVTX
COMPANIES
2
ACTIVE SINCE
Sep 2021
MARKETPEEL · /INSIDER/0001247024DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback